U.S. MARKETS FOR INTERVENTIONAL PERIPHERAL VASCULAR DISEASE MANAGEMENT PRODUCTS AND TECHNOLOGIES

240 Pages | 65 Exhibits | 2009 Analysis | Forecasts Through 2013 Product Family: Market Reports




OVERVIEW:
Peripheral vascular disease (PVD) refers to those conditions that affect the vessels carrying blood to and from the extremities as well as the tissues and organs of the abdominal and pelvic cavities. These conditions include aneurysm, chronic venous insufficiency, deep-vein thrombosis, peripheral artery disease, and pulmonary embolism.

In 2008, approximately 3.6 million interventional procedures for the diagnosis and treatment of PVD were performed in the United States (U.S.), generating an estimated $1.3 billion in corresponding product sales. The number of diagnostic and therapeutic PVD interventions is expected to increase at a compound annual rate of 3.7% during the forecast period covered by this report, reaching an estimated 4.3 million in the year 2013. Sales of products to perform these procedures-angiography, atherectomy, embolization, intravascular ultrasound, percutaneous transluminal angioplasty, thrombectomy, thrombolysis, vascular puncture closure, and vena cava filter systems-are projected to increase at a higher compound annual rate of 8.0% over the next half-decade, reaching nearly $2.0 billion in the year 2013.

This dynamic, new report from Medtech Insight includes analyses of products, current and emerging markets, competitors, and opportunities for suppliers of interventional devices for the diagnosis and treatment of PVD in the U.S.

Covered topics in this report include angiography devices; catheter-directed thrombolysis products; chronic total occlusion crossing systems; cryotherapy systems; drug-eluting balloon systems; endovascular embolization products; growth factor- and stem cell-/progenitor cell-based therapeutic angiogenesis; intravascular ultrasound systems; mechanical atherectomy systems; mechanical and pharmaco-mechanical thrombectomy products; peripheral transluminal angioplasty devices; and vena cava filters.



TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Interventional Peripheral Vascular Disease Diagnostic Products Market 
	a. Angiography 
	b. Intravascular Ultrasound 
ii. Interventional Peripheral Vascular Disease Treatment Products Market 
	a. Percutaneous Transluminal Angioplasty 
	b. Catheter-Directed Thrombolysis 
	c. Chronic Total Occlusion Crossing 
	d. Mechanical Atherectomy 
	e. Endovascular Embolization 
	f. Thrombectomy 
	g. Vena Cava Filter Placement 
	h. Endovascular Cryotherapy 
	i. Drug-Eluting Balloon Angioplasty 
iii. Methodology 

Exhibit ES-1: Interventional Peripheral Vascular Disease Management, Combined Procedure Volumes Forecast, 2008-2013 
Exhibit ES-2: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast, 2008-2013 
Exhibit ES-3: Interventional Peripheral Vascular Disease Management Products, Combined Market Forecast,  by Segment 2008-2013 
Exhibit ES-4: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013 
Exhibit ES-5: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013 
Exhibit ES-6: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013 
Exhibit ES-7: Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013 
Exhibit ES-8: Powered Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013 
Exhibit ES-9: Mechanical Atherectomy Systems, Market Forecast, 2008-2013 
Exhibit ES-10: Endovascular Embolization Products, Market Forecast, 2008-2013 
Exhibit ES-11: Thrombectomy Systems,Market Forecast, 2008-2013 
Exhibit ES-12: Vena Cava Filter Systems, Market Forecast, 2008-2013 
Exhibit ES-13: Endovascular Cryotherapy Systems, Market Forecast,  2008-2013 
Exhibit ES-14: Drug Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013 

1. PERIPHERAL VASCULAR DISEASE OVERVIEW

1.1 Anatomy and Physiology of the Circulatory System 
1.2 Types of Peripheral Vascular Disease 
	1.2.1 Peripheral Artery Disease 
		1.2.1.1 Etiology 
		1.2.1.2 Epidemiology 
	1.2.2 Aneurysm 
		1.2.2.1 Etiology 
		1.2.2.2 Epidemiology 
	1.2.3 Deep Vein Thrombosis and Pulmonary Embolism 
		1.2.3.1 Etiology 
		1.2.3.2 Epidemiology 
	1.2.4 Chronic Venous Insufficiency 
		1.2.4.1 Etiology 
		1.2.4.2 Epidemiology 

Exhibit 1-1: 2009, Peripheral Artery Disease, Facts and Figures 
Exhibit 1-2: 2009, Aortic Aneurysm, Facts and Figures 
Exhibit 1-3: 2009, Deep Vein Thrombosis, Facts and Figures 
Exhibit 1-4: Classification of Chronic Venous Insufficiency 
Exhibit 1-5: 2009, Chronic Venous Insufficiency, Facts and Figures 

2. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE DIAGNOSTIC PRODUCTS MARKET

2.1 Noninvasive Peripheral Vascular Disease Diagnostics 
	2.1.1 Ankle/Brachial Index 
	2.1.2 Exercise Tolerance Testing 
	2.1.3 Imaging Methods 
		2.1.3.1 Computed Tomography 
		2.1.3.2 Magnetic Resonance Imaging 
		2.1.3.3 Thermography 
		2.1.3.4 Ultrasound Imaging 
	2.1.4 Photoplethysmography and Air Plethysmography 
2.2 Interventional Peripheral Vascular Disease Diagnostics, Market Analysis 
	2.2.1 Angiography 
		2.2.1.1 Types 
			2.2.1.1.1 Peripheral Arterial Angiography 
			2.2.1.1.2 Peripheral Venous Angiography 
		2.2.1.2 Procedures/Technologies 
		2.2.1.3 Products 
		2.2.1.4 Market Forecast 
		2.2.1.5 Competitors 
	2.2.2 Intravascular Ultrasound 
		2.2.2.1 Procedures/Technologies 
		2.2.2.2 Products 
		2.2.2.3 Market Forecast 
		2.2.2.4 Competitors 

Exhibit 2-1: Interventional Peripheral Vascular Disease Diagnosis, Combined Procedure Volumes Forecast, 2008-2013 
Exhibit 2-2: Interventional Peripheral Vascular Disease Diagnostic Products, Combined Market Forecast, 2008-2013 
Exhibit 2-3: Peripheral Angiography, Procedure Volumes Forecast, 2008-2013 
Exhibit 2-4: 2009, Selected Angiography Catheters 
Exhibit 2-5: 2009, Selected Diagnostic Guidewires 
Exhibit 2-6: 2009, Selected Introducers/Sheaths 
Exhibit 2-7: Angiography Devices for Peripheral Vascular Disease Diagnostics, Market Forecast, 2008-2013 
Exhibit 2-8: 2008, Market for Angiography Devices for Peripheral Vascular Disease Diagnostics, Share by Supplier 
Exhibit 2-9: Intravascular Ultrasound, Procedure Volumes Forecast, 2008-2013 
Exhibit 2-10: 2009, Selected Intravascular Ultrasound Catheters 
Exhibit 2-11: Intravascular Ultrasound Catheters, Market Forecast, 2008-2013 
Exhibit 2-12: 2008, Intravascular Ultrasound Catheters Market, Share by Supplier 

3. INTERVENTIONAL PERIPHERAL VASCULAR DISEASE TREATMENT PRODUCTS MARKET

3.1 Noninvasive Peripheral Vascular Disease Treatments 
	3.1.1 Lifestyle Changes 
		3.1.1.1 Exercise Therapy 
		3.1.1.2 Diet Modification 
		3.1.1.3 Smoking Cessation 
		3.1.1.4 Compression Therapy 
	3.1.2 Drug Therapy 
		3.1.2.1 Anticoagulants and Antiplatelet Drugs 
		3.1.2.2 Dyslipidemia Management Drugs 
3.2 Surgical/Endoscopic Peripheral Vascular Disease Treatments 
	3.2.1 Femoropopliteal Bypass Graft Surgery 
	3.2.2 Thromboendarterectomy 
	3.2.3 Chronic Venous Insufficiency and Venous Ulceration Treatments 
		3.2.3.1 Deep Vein Reconstruction 
		3.2.3.2 Open Subfascial Perforator Surgery 
		3.2.3.3 Skin Grafting 
		3.2.3.4 Subfascial Endoscopic Perforator Surgery 
		3.2.3.5 Superficial Vein Stripping 
3.3 Interventional Peripheral Vascular Disease Treatments, Market Analysis 
	3.3.1 Percutaneous Transluminal Angioplasty 
		3.3.1.1 Procedures/Technologies 
		3.3.1.2 Products 
			3.3.1.2.1 Balloon Catheters 
			3.3.1.2.2 Guiding Catheters 
			3.3.1.2.3 Guidewires 
			3.3.1.2.4 Introducers/Sheaths 
			3.3.1.2.5 Accessories 
		3.3.1.3 Market Forecast 
		3.3.1.4 Competitors 
	3.3.2 Catheter-Directed Thrombolysis 
		3.3.2.1 Procedures/Technologies 
		3.3.2.2 Products 
		3.3.2.3 Market Forecast 
		3.3.2.4 Competitors 
	3.3.3 Chronic Total Occlusion Crossing 
		3.3.3.1 Procedures/Technologies 
		3.3.3.2 Products 
		3.3.3.3 Market Forecast 
		3.3.3.4 Competitors 
	3.3.4 Mechanical Atherectomy 
		3.3.4.1 Procedures/Technologies 
		3.3.4.2 Products 
		3.3.4.3 Market Forecast 
		3.3.4.4 Competitors 
	3.3.5 Endovascular Embolization 
		3.3.5.1 Procedures/Technologies 
		3.3.5.2 Products 
		3.3.5.3 Market Forecast 
		3.3.5.4 Competitors 
	3.3.6 Thrombectomy 
		3.3.6.1 Procedures/Technologies 
		3.3.6.2 Products 
		3.3.6.3 Market Forecast 
		3.3.6.4 Competitors 
	3.3.7 Vena Cava Filter Placement 
		3.3.7.1 Procedures/Technologies 
		3.3.7.2 Products 
		3.3.7.3 Market Forecast 
		3.3.7.4 Competitors 
	3.3.8 Other/Emerging 
		3.3.8.1 Endovascular Cryotherapy 
			3.3.8.1.1 Procedures/Technologies 
			3.3.8.1.2 Products 
			3.3.8.1.3 Market Forecast 
		3.3.8.2 Drug-Eluting Balloon Angioplasty 
			3.3.8.2.1 Procedures/Technologies 
			3.3.8.2.2 Products 
			3.3.8.2.3 Market Forecast 

Exhibit 3-1: Interventional Peripheral Vascular Disease Treatment, Combined Procedure  Volumes Forecast, 2008-2013 
Exhibit 3-2: Interventional Peripheral Vascular Disease Treatment Products,  Combined Market Forecast, 2008-2013 
Exhibit 3-3: Percutaneous Transluminal Angioplasty, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-4: 2009, Selected Percutaneous Transluminal Angioplasty  Balloon Catheters 
Exhibit 3-5: Percutaneous Transluminal Angioplasty Devices, Market Forecast, 2008-2013 
Exhibit 3-6: 2008, Percutaneous Transluminal Angioplasty Devices Market, Share by Supplier 
Exhibit 3-7: Catheter-Directed Thrombolysis, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-8: 2009, Selected Catheter-Directed Thrombolysis Systems 
Exhibit 3-9: Catheter-Directed Thrombolysis Systems, Market Forecast, 2008-2013 
Exhibit 3-10: 2008, Catheter-Directed Thrombolysis Systems Market, Share by Supplier 
Exhibit 3-11: Powered Chronic Total Occlusion Crossing, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-12: 2009, Selected Powered Chronic Total Occlusion Crossing Systems 
Exhibit 3-13: Powered Chronic Total Occlusion Crossing Systems, Market Forecast, 2008-2013 
Exhibit 3-14: 2008, Powered Chronic Total Occlusion Crossing Systems Market, Share by Supplier 
Exhibit 3-15: Mechanical Atherectomy, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-16: 2009, Selected Mechanical Atherectomy Systems 
Exhibit 3-17: Mechanical Atherectomy Systems, Market Forecast, 2008-2013 
Exhibit 3-18: 2008, Mechanical Atherectomy Systems Market, Share by Supplier 
Exhibit 3-19: Endovascular Embolization, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-20: 2009, Selected Endovascular Embolization Products 
Exhibit 3-21: Endovascular Embolization Products, Market Forecast, 2008-2013 
Exhibit 3-22: 2008, Endovascular Embolization Products Market, Share by Supplier 
Exhibit 3-23: Thrombectomy, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-24: 2009, Selected Thrombectomy Systems 
Exhibit 3-25: Thrombectomy Systems, Market Forecast, 2008-2013 
Exhibit 3-26: 2008, Thrombectomy Systems Market, Share by Supplier 
Exhibit 3-27: Vena Cava Filter Placement, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-28: 2009, Selected Vena Cava Filter Systems 
Exhibit 3-29: Vena Cava Filter Systems, Market Forecast, 2008-2013 
Exhibit 3-30: 2008, Vena Cava Filter Systems Market, Share by Supplier 
Exhibit 3-31: Endovascular Cryotherapy, Procedure Volumes Forecast,  2008-2013 
Exhibit 3-32: Endovascular Cryotherapy Systems,Market Forecast, 2008-2013 
Exhibit 3-33: Drug-Eluting Balloon Angioplasty, Procedure Volumes Forecast, 2008-2013 
Exhibit 3-34: Drug-Eluting Balloon Angioplasty Systems, Market Forecast, 2008-2013 

4. COMPANY PROFILES

4.1 Abbott Laboratories 
4.2 AngioDynamics, Inc. 
4.3 Arrow International/Teleflex, Inc. 
4.4 Bacchus Vascular/Covidien LTD 
4.5 C.R. Bard, Inc. 
4.6 BioSphere Medical, Inc. 
4.7 Boston Scientific Corporation 
4.8 B. Braun Melsungen AG 
4.9 Cardiovascular Systems, Inc. 
4.10 Cook Group 
4.11 Cordis Corporation/Johnson & Johnson 
4.12 ev3, Inc. 
4.13 MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group 
4.14 Medtronic, Inc. 
4.15 Spectranetics Corporation 
4.16 Terumo Interventional Systems/Terumo Corporation 
4.17 Volcano Corporation 

APPENDIX:  COMPANY LISTING 


COMPANIES COVERED:

  1. Abbott Laboratories
  2. AngioDynamics, Inc.
  3. Arrow International/Teleflex, Inc.
  4. Bacchus Vascular/Covidien LTD
  5. C.R. Bard, Inc.
  6. BioSphere Medical, Inc.
  7. Boston Scientific Corporation
  8. B. Braun Melsungen AG
  9. Cardiovascular Systems, Inc.
  10. Cook Group
  11. Cordis Corporation/Johnson & Johnson
  12. ev3, Inc.
  13. MEDRAD Interventional Possis/Bayer HealthCare/Bayer Group
  14. Medtronic, Inc.
  15. Spectranetics Corporation
  16. Terumo Interventional Systems/Terumo Corporation
  17. Volcano Corporation
Contact Us

Need help finding medtech research? Let us help you!